Article
Targeted cancer therapy induces APOBEC fuelling the evolution of drug resistance
2020-12-18
Abstract excerpt
<h4>Introductory paragraph</h4> The clinical success of targeted cancer therapy is limited by drug resistance that renders cancers lethal in patients 1-4 . Human tumours can evolve therapy resistance by acquiring de novo genetic alterations and increased heterogeneity via mechanisms that remain incompletely understood 1 . Here, through parallel analysis of human clinical samples, tumour xenograft and cell line...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 44b756bd-c7e8-5740-8ffb-5b84e4f9e4d5
- DOI
- 10.1101/2020.12.18.423280
